Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B.
Shang-Chin HuangTung-Hung SuTai-Chung TsengSih-Han LiaoShih-Jer HsuChun-Ming HongTing-Yuan LanChen-Hua LiuHung-Chih YangChun-Jen LiuJia-Horng KaoPublished in: The American journal of gastroenterology (2024)
Concurrent and new-onset MDs increase the risks of cirrhosis and cirrhotic complications in patients with CHB, independent of hepatic steatosis. Proactively investigating metabolic comorbidities in CHB is critical to stratify the risk of liver disease progression.